IGF1R and Alzheimer disease: In a transgenic mouse model of AD (AβPP/PS1), treatment with picropodophyllin, a selective IGF-1R inhibitor, reduced levels of insoluble Aβ1-40 and Aβ1-42 in the temporal cortex but not in the hippocampus (275).